{
    "nct_id": "NCT01059877",
    "title": "Assessing the Effect of 1072nm Infrared (IR) Phototherapy on the Behavioral and Cognitive Symptoms Associated With Early and Mid-stage Dementia: a Randomized Placebo-controlled Clinical Trial.",
    "status": "COMPLETED",
    "last_update_time": "2018-08-29",
    "description_brief": "This study will employ a double-blind, placebo-controlled approach to assess the effect of 1072nm infrared (IR) phototherapy on the behavioral and cognitive symptoms associated with early and mid-stage dementia.",
    "description_detailed": "What hypotheses are you testing?\n\nWe are seeking to determine if the provision of brief, repeated exposure to 1072nm infrared stimulation of the cortex surface improves cognitive and behavioral functioning as indicated by normalization of EEG activity, increased cerebral oxygenation and demonstrated improvement on standardized neuropsychological measures.\n\nIntensive near infrared stimulation has been shown to be effective in accelerating healing of injuries and functional modification including increasing blood flow and perfusion. Dementia research has suggested that hypoperfusion is a significant underlying mechanism in the progression of dementia. Infrared spectroscopy has been shown effective in the non-invasive measurement of changes in cerebral oxygenation and perfusion. This study therefore seeks to explore whether the increasing of regional cerebral perfusion and oxygenation using infrared light stimulation will result in improved cognitive and behavioral functioning.",
    "phase": [
        "NA"
    ],
    "study_type": "INTERVENTIONAL",
    "primary_purpose": "TREATMENT",
    "results": {
        "participantFlowModule": {
            "groups": [
                {
                    "id": "FG000",
                    "title": "Treatment Group",
                    "description": "received actual tx"
                },
                {
                    "id": "FG001",
                    "title": "Placebo Group",
                    "description": "received placebo tx"
                }
            ],
            "periods": [
                {
                    "title": "Overall Study",
                    "milestones": [
                        {
                            "type": "STARTED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "6"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "5"
                                }
                            ]
                        },
                        {
                            "type": "COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "6"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "3"
                                }
                            ]
                        },
                        {
                            "type": "NOT COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "2"
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "baselineCharacteristicsModule": {
            "groups": [
                {
                    "id": "BG000",
                    "title": "Treatment Group",
                    "description": "received actual tx"
                },
                {
                    "id": "BG001",
                    "title": "Placebo Group",
                    "description": "received placebo tx"
                },
                {
                    "id": "BG002",
                    "title": "Total",
                    "description": "Total of all reporting groups"
                }
            ],
            "denoms": [
                {
                    "units": "Participants",
                    "counts": [
                        {
                            "groupId": "BG000",
                            "value": "6"
                        },
                        {
                            "groupId": "BG001",
                            "value": "3"
                        },
                        {
                            "groupId": "BG002",
                            "value": "9"
                        }
                    ]
                }
            ],
            "measures": [
                {
                    "title": "Age, Continuous",
                    "paramType": "MEAN",
                    "dispersionType": "FULL_RANGE",
                    "unitOfMeasure": "years",
                    "classes": [
                        {
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "BG000",
                                            "value": "6"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "9"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "80",
                                            "lowerLimit": "74",
                                            "upperLimit": "89"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "84",
                                            "lowerLimit": "76",
                                            "upperLimit": "96"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "81",
                                            "lowerLimit": "74",
                                            "upperLimit": "96"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Sex: Female, Male",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "BG000",
                                            "value": "6"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "9"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "title": "Female",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "4"
                                        }
                                    ]
                                },
                                {
                                    "title": "Male",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "5"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Race and Ethnicity Not Collected",
                    "populationDescription": "Race and Ethnicity were not collected from any participant.",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Region of Enrollment",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "title": "United States",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "BG000",
                                            "value": "6"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "9"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "6"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "9"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Delayed word recall",
                    "description": "Delayed Word Recall is a subscale of the Alzheimer's Disease Assessment Scale-Cognitive (ADAS-Cog), a measure of cognitive impairment. Higher scores indicate greater impairment. Range: 0-10.",
                    "paramType": "MEAN",
                    "dispersionType": "FULL_RANGE",
                    "unitOfMeasure": "units on a scale",
                    "classes": [
                        {
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "BG000",
                                            "value": "6"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "9"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0.50",
                                            "lowerLimit": "0",
                                            "upperLimit": "1"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "1.33",
                                            "lowerLimit": "0",
                                            "upperLimit": "4"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0.798",
                                            "lowerLimit": "0",
                                            "upperLimit": "4"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Trail making A",
                    "description": "The Trail Making Test (TMT) is used to investigate deficits in cognitive processing speed and executive function. Part A consists of 25 circles on a piece of paper with the numbers 1-25 in random order in the circles. The patient starts with number one and draws a line from that circle to the circle with number two, etc. to number 25. More errors indicate poorer performance.",
                    "paramType": "MEAN",
                    "dispersionType": "FULL_RANGE",
                    "unitOfMeasure": "errors at task",
                    "classes": [
                        {
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "BG000",
                                            "value": "6"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "9"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0.83",
                                            "lowerLimit": "0",
                                            "upperLimit": "5"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "9.00",
                                            "lowerLimit": "3",
                                            "upperLimit": "14"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "3.56",
                                            "lowerLimit": "0",
                                            "upperLimit": "14"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "outcomeMeasuresModule": {
            "outcomeMeasures": [
                {
                    "type": "PRIMARY",
                    "title": "Alzheimer Disease Assessment Scale-Cognitive (ADAS-Cog) Delayed Word Recall.",
                    "description": "Delayed Word Recall is a subscale of the Alzheimer's Disease Assessment Scale-Cognitive (ADAS-Cog), a measure of cognitive impairment. Higher scores indicate greater impairment. Range: 0-10. Measures were taken within 72 hours of the first day of treatment and within 72 hours following the 28th day of treatment. Outcome measure was calculated by subtracting pretest from post test ADAS-Cog measurements.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Full Range",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Post-tx (total intervention period = 28 days) scores to be compared to baseline scores.",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Treatment Group",
                            "description": "received actual tx"
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo Group",
                            "description": "received placebo tx"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "6"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "3"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "3.17",
                                            "lowerLimit": "2",
                                            "upperLimit": "4"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "3",
                                            "lowerLimit": "3",
                                            "upperLimit": "3"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "adverseEventsModule": {
            "frequencyThreshold": "0",
            "timeFrame": "Course of study, approx. 6 months",
            "eventGroups": [
                {
                    "id": "EG000",
                    "title": "Treatment Group",
                    "description": "received actual tx",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 6,
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 6,
                    "otherNumAffected": 0,
                    "otherNumAtRisk": 6
                },
                {
                    "id": "EG001",
                    "title": "Placebo Group",
                    "description": "received placebo tx",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 3,
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 3,
                    "otherNumAffected": 0,
                    "otherNumAtRisk": 3
                }
            ]
        },
        "moreInfoModule": {
            "certainAgreement": {
                "piSponsorEmployee": false,
                "restrictiveAgreement": false
            },
            "pointOfContact": {
                "title": "Marvin Berman, PhD",
                "organization": "QuietMind Foundation",
                "email": "marvinberman@quietmindfdn.org",
                "phone": "610.940.0488"
            }
        }
    },
    "target_category": "Cognitive enhancer",
    "drug": [
        "1072 nm infrared phototherapy (transcranial photobiomodulation device)"
    ],
    "placebo": [
        "Simulated (sham) photobiomodulation device"
    ],
    "explanation_target": [
        "Reason: The trial tests transcranial 1072 nm infrared phototherapy (photobiomodulation) to improve cognitive and behavioral functioning in early\u2013mid dementia; the protocol lists cognitive measures (ADAS\u2011Cog) as a primary outcome, indicating a primary aim of improving cognition rather than delivering a disease\u2011modifying biologic or small molecule. \ue200cite\ue202turn0search0\ue201",
        "Act (extracted trial details): Intervention = 1072 nm infrared photobiomodulation (transcranial device); Control = Photobiomodulation SIMULATED (sham). Primary cognitive outcome (ADAS\u2011Cog delayed recall) is specified in the trial listing. \ue200cite\ue202turn0search0\ue201",
        "Support from literature: Systematic reviews and meta\u2011analyses find that phototherapy/near\u2011infrared photobiomodulation is associated with short\u2011term improvements in global and domain\u2011specific cognition (attention, executive function, working memory) in dementia, supporting classifying this intervention as a cognitive\u2011enhancing non\u2011pharmacologic therapy. \ue200cite\ue202turn0search3\ue201",
        "Additional supporting studies: Pilot and clinical studies of near\u2011infrared transcranial photobiomodulation (e.g., ~1068 nm and other NIR wavelengths) report improvements in memory and processing speed in older adults, and 1072 nm has been used in other clinical contexts (wound healing, immune response), confirming the intervention is a NIR phototherapy device rather than a drug. \ue200cite\ue202turn0search4\ue202turn0search2\ue201",
        "Reflect: Classification rationale and ambiguity \u2014 I classify this as 'Cognitive enhancer' because the intervention is a non\u2011pharmacologic NIR device aimed at improving cognitive performance (primary outcome ADAS\u2011Cog) and literature frames NIR PBM as a cognitive intervention. However, the trial explicitly also targets behavioral/neuropsychiatric symptoms, so there is overlap with 'neuropsychiatric symptom improvement'; users should note the dual cognitive+behavioral intent. Similar ongoing/related PBM trials for Alzheimer\u2019s risk also focus on cognitive enhancement. \ue200cite\ue202turn0search0\ue202turn0search6\ue201"
    ],
    "agent_type": "J) Metabolism and Bioenergetics",
    "explanation_agent": [
        "Reason: The intervention is transcranial near\u2011infrared photobiomodulation (1072 nm) whose primary, well\u2011described mechanism is modulation of mitochondrial function (photoactivation of cytochrome c oxidase / mitochondrial electron transport) with downstream increases in ATP, altered redox signaling and bioenergetics \u2014 i.e., an effect on cellular metabolism and bioenergetics. \ue200cite\ue202turn0search6\ue202turn0search4\ue201",
        "Act: Extracted trial details from the description \u2014 Intervention = 1072 nm transcranial photobiomodulation device (PBM); Control = sham photobiomodulation; Primary outcome = cognitive measures (ADAS\u2011Cog). PBM\u2019s clinical aim in dementia trials is cognitive enhancement, but its mechanism maps to mitochondrial bioenergetics (not a specific amyloid/tau/ApoE molecular target). Supporting evidence shows PBM is associated with short\u2011term cognitive improvements in dementia trials. \ue200cite\ue202turn0search2\ue201",
        "Reflect: Classification as 'J) Metabolism and Bioenergetics' fits because the biological target/action of PBM is on cellular mitochondria and metabolic/energetic pathways (cytochrome c oxidase and downstream ATP/redox signaling). PBM can also modulate inflammation and synaptic function (overlap with CADRO categories F and M), but the most specific CADRO match for the described mechanism is J. If the trial had explicitly targeted neurogenesis or synaptic plasticity as the primary mechanistic claim, a different category could be considered; given the mechanistic literature and typical framing of PBM, J is most appropriate. \ue200cite\ue202turn0search3\ue202turn0search5\ue201",
        "Web search results (supporting sources):",
        "1) 'Phototherapy for Cognitive Function in Patients With Dementia: A Systematic Review and Meta\u2011Analysis' \u2014 pooled evidence that NIR photobiomodulation is associated with short\u2011term cognitive improvements in dementia. \ue200cite\ue202turn0search2\ue201",
        "2) 'Photobiomodulation\u2014Underlying Mechanism and Clinical Applications' (review, MDPI/PMC) \u2014 describes mitochondrial cytochrome c oxidase and downstream increases in ATP, Ca2+, ROS and signaling as core PBM mechanisms. \ue200cite\ue202turn0search6\ue201",
        "3) 'Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation' (review, PubMed) \u2014 reviews CCO (complex IV) as the primary chromophore and mitochondrial bioenergetic/redox effects. \ue200cite\ue202turn0search4\ue201",
        "4) 'Differential effects of 808\u2011nm light on electron transport chain enzymes in isolated mitochondria' \u2014 experimental work on wavelength\u2011specific mitochondrial effects, underscoring mitochondria as the mechanistic focus. \ue200cite\ue202turn0search3\ue201",
        "5) 'Photobiomodulation directly benefits primary neurons ...: role of cytochrome c oxidase' \u2014 experimental neuronal data supporting CCO/ATP as a mediator of PBM neuroprotection. \ue200cite\ue202turn0search5\ue201"
    ]
}